TRADE WITH CONVICTION

Wednesday, July 15, 2026
RSS



IPO
Lisata Therapeutics' Tender Offer: What It Means for Investors

Kuva Labs proposes a tender offer for Lisata Therapeutics, potentially valuing shares at $7.00 each. What does this mean…

Marcus Rivera • Jun 10, 2026
IPO
Canfor Expands Market Reach with PinkWood Acquisition

Canfor's $68 million acquisition of PinkWood's I-joist business enhances its portfolio and positions it for growth in th…

Sarah Chen • Jun 10, 2026
IPO
Payoneer Global's Stock Surge: What a $2.7B Acquisition Could Mean

Nuvei's potential $2.7 billion acquisition of Payoneer could reshape the fintech landscape, impacting investor sentiment…

Sarah Chen • Jun 9, 2026
IPO
GSK's $10.6 Billion Bet on Nuvalent: What It Means for the Biotech Sector

GSK's acquisition of Nuvalent for $10.6 billion signifies a strategic move in the precision oncology market, impacting i…

Catherine Walsh • Jun 9, 2026
IPO
G2 Goldfields Gains ISS Support: What It Means for Shareholders

G2 Goldfields receives ISS backing for its merger with G Mining, raising questions about its future and the Canadian min…

Diana Kowalski • Jun 4, 2026
IPO
Factorial Energy's SPAC Merger: What It Means for the Future of Energy Technology Investments

Factorial Energy's merger with Cartesian Growth Corporation could reshape energy tech investments as it transitions to t…

Sarah Chen • May 28, 2026
IPO
ProLogium's SPAC Merger: A New Frontier in Solid-State Battery Technology

ProLogium's merger with TDAC marks a significant step in solid-state battery innovation within the EV sector.

Catherine Walsh • May 27, 2026
IPO
SpaceX's Retail IPO: What Investors Need to Know

SpaceX's IPO is set to shake up the market with unique selling structures and implications for retail investors.

Marcus Rivera • May 21, 2026
IPO
AvalonBay and Equity Residential Merge: A New Era in the REIT Sector

AvalonBay and Equity Residential announce an all-stock merger, reshaping the landscape of the residential REIT market.

Sarah Chen • May 21, 2026
IPO
Angelini Pharma's $4.1 Billion Acquisition of Catalyst Pharmaceuticals Explained

Angelini Pharma's acquisition of Catalyst Pharmaceuticals for $4.1 billion marks a major strategic move in the U.S. heal…

Catherine Walsh • May 7, 2026
IPO
Vireo Growth Expands Footprint with FLUENT Acquisition

Vireo Growth's acquisition of FLUENT marks a significant consolidation in the cannabis industry, highlighting sector mat…

James McAllister • Apr 30, 2026
IPO
United Airlines' Merger Musings: A Precursor to Industry Consolidation?

United Airlines CEO Scott Kirby's merger considerations hint at significant shifts in the airline industry.

Catherine Walsh • Apr 15, 2026